U.S. flag

An official website of the United States government

NM_000518.4(HBB):c.364G>A (p.Glu122Lys) AND Hb SS disease

Germline classification:
Pathogenic/Likely pathogenic (3 submissions)
Last evaluated:
May 9, 2018
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000202511.16

Allele description [Variation Report for NM_000518.4(HBB):c.364G>A (p.Glu122Lys)]

NM_000518.4(HBB):c.364G>A (p.Glu122Lys)

Genes:
LOC110006319:beta-globin gene 3' regulatory region [Gene]
HBB:hemoglobin subunit beta [Gene - OMIM - HGNC]
LOC107133510:origin of replication at HBB [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.4
Genomic location:
Preferred name:
NM_000518.4(HBB):c.364G>A (p.Glu122Lys)
Other names:
E121K
HGVS:
  • NC_000011.10:g.5225678C>T
  • NG_000007.3:g.71938G>A
  • NG_046672.1:g.3613C>T
  • NG_053049.1:g.1999C>T
  • NG_059281.1:g.6394G>A
  • NM_000518.5:c.364G>AMANE SELECT
  • NP_000509.1:p.Glu122Lys
  • NP_000509.1:p.Glu122Lys
  • LRG_1232t1:c.364G>A
  • LRG_1232:g.6394G>A
  • LRG_1232p1:p.Glu122Lys
  • NC_000011.9:g.5246908C>T
  • NM_000518.4:c.364G>A
  • P68871:p.Glu122Lys
Protein change:
E122K; Glu121Lys
Links:
HBVAR: 510; UniProtKB: P68871#VAR_003049; OMIM: 141900.0202; OMIM: 141900.0245; OMIM: 141900.0507; dbSNP: rs33946267
NCBI 1000 Genomes Browser:
rs33946267
Molecular consequence:
  • NM_000518.5:c.364G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hb SS disease (SCD)
Synonyms:
Sickle cell anemia; Sickle cell disease; HbS disease; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0011382; MedGen: C0002895; Orphanet: 232; OMIM: 603903

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000190692GeneReviews
no classification provided
not providedgermlineliterature only

SCV001163644Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicgermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001423601Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(May 9, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, literature only
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From GeneReviews, SCV000190692.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature onlynot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV001163644.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital, SCV001423601.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

[ACMG/AMP: PS4, PM2, PM3, PP5] This alteration has a prevalence that is significantly increased compared with controls (RR/OR > 5; CI does not include 1.0) [PS4], is absent from or rarely observed in large-scale population databases [PM2], is detected in trans with a known pathogenic variant [PM3], was reported as a pathogenic/likely pathogenic alteration by a reputable source (ClinVar or other correspondence from a clinical testing laboratory) [PP5].

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 5, 2025